Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Adenosine kinase inhibition promotes survival of fetal adenosine deaminase–deficient thymocytes by blocking dATP accumulation
C. Justin Van De Wiele, … , Hong Jiang, Linda F. Thompson
C. Justin Van De Wiele, … , Hong Jiang, Linda F. Thompson
Published August 1, 2002
Citation Information: J Clin Invest. 2002;110(3):395-402. https://doi.org/10.1172/JCI15683.
View: Text | PDF
Article Genetics

Adenosine kinase inhibition promotes survival of fetal adenosine deaminase–deficient thymocytes by blocking dATP accumulation

  • Text
  • PDF
Abstract

Research Article

Authors

C. Justin Van De Wiele, James G. Vaughn, Michael R. Blackburn, Catherine A. Ledent, Marlene Jacobson, Hong Jiang, Linda F. Thompson

×

Figure 5

Options: View larger image (or click on image) Download as PowerPoint
An adenosine receptor agonist does not mimic and an adenosine receptor a...
An adenosine receptor agonist does not mimic and an adenosine receptor antagonist does not prevent the effects of ADA deficiency in FTOC. FTOCs were performed with C57BL/6 thymuses at day 15 of gestation in the presence of (a) 0.1% DMSO (carrier for NECA), (b) 100 μM NECA, (c) 0.1 mM acetic acid (carrier for XAC), (d) 5 μM dCF, (e) 25 μM XAC, or (f) 25 μM XAC plus 5 μM dCF. At the end of culture (6 days for DMSO and NECA or 2 days for XAC with or without dCF), thymocytes were harvested, counted, and stained with FITC-anti-CD4, PE-anti-CD8, and PI to exclude dead cells. The data are representative of one experiment out of six for NECA and one out of three for XAC.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts